Distinct Modulation of Spontaneous and GABA-Evoked Gating by Flurazepam Shapes Cross-Talk Between Agonist-Free and Liganded GABAA Receptor Activity
Open Access
- 28 August 2018
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cellular Neuroscience
- Vol. 12, 237
Abstract
GABAA receptors (GABAARs) play a crucial inhibitory role in the CNS. Benzodiazepines (BDZs) are positive modulators of specific subtypes of GABAARs, but the underlying mechanism remains obscure. Early studies demonstrated the major impact of BDZs on binding and more recent investigations indicated gating, but it is unclear which transitions are affected. Moreover, the upregulation of GABAAR spontaneous activity by BDZs indicates their impact on receptor gating but the underlying mechanisms remain unknown. Herein, we investigated the effect of a BDZ (flurazepam) on the spontaneous and GABA-induced activity for wild-type (WT, α1β2γ2) and mutated (at the orthosteric binding site α1F64) GABAARs. Surprisingly, in spite of the localization at the binding site, these mutations increased the spontaneous activity. Flurazepam (FLU) upregulated this activity for mutants and WT receptors to a similar extent by affecting opening/closing transitions. Spontaneous activity affected GABA-evoked currents and is manifested as an overshoot after agonist removal that depended on the modulation by BDZs. We explain the mechanism of this phenomenon as a cross-desensitization of ligand-activated and spontaneously active receptors. Moreover, due to spontaneous activity, FLU-pretreatment and co-application (agonist + FLU) protocols yielded distinct results. We provide also the first evidence that GABAAR may enter the desensitized state in the absence of GABA in a FLU-dependent manner. Based on our data and model simulations, we propose that FLU affects agonist-induced gating by modifying primarily preactivation and desensitization. We conclude that the mechanisms of modulation of spontaneous and ligand-activated GABAAR activity concerns gating but distinct transitions are affected in spontaneous and agonist-evoked activity.Keywords
Funding Information
- Narodowe Centrum Nauki
This publication has 39 references indexed in Scilit:
- Comparison of kinetic and pharmacological profiles of recombinant α1γ2L and α1β2γ2L GABAA receptors – A clue to the role of intersubunit interactionsEuropean Journal of Pharmacology, 2016
- Glycine receptor mechanism elucidated by electron cryo-microscopyNature, 2015
- Zolpidem and eszopiclone prime α1β2γ2 GABAA receptors for longer duration of activityBritish Journal of Pharmacology, 2015
- Mechanism of action of benzodiazepines on GABA A receptorsBritish Journal of Pharmacology, 2006
- Benzodiazepine modulation of partial agonist efficacy and spontaneously active GABAA receptors supports an allosteric model of modulationBritish Journal of Pharmacology, 2005
- Tonic inhibition in mouse hippocampal CA1 pyramidal neurons is mediated by α5 subunit-containing γ-aminobutyric acid type A receptorsProceedings of the National Academy of Sciences, 2004
- Formation and plasticity of GABAergic synapses: physiological mechanisms and pathophysiological implicationsPharmacology & Therapeutics, 2003
- Generating diversity at GAB Aergic synapsesTrends in Neurosciences, 2001
- Zinc Inhibits Miniature GABAergic Currents by Allosteric Modulation of GABAAReceptor GatingJournal of Neuroscience, 2000
- High-efficiency transformation of mammalian cells by plasmid DNA.Molecular and Cellular Biology, 1987